- TV Footage
- Integrated Annual Reports
- Quarterly Statements
- Sustainability Report
- Newsletter Overview
- Social Media
- Media Contact
Leverkusen, January 23, 2020 – Bijoy Sagar (50) will be Bayer’s new Chief Information Technology & Digital Transformation Officer (CIDO) effective June 1, 2020. The move sees Daniel Hartert (61) leave Bayer after 12 years of service retiring from his corporate career. “In Bijoy, we have found a successor who will continue to drive forward our digital transformation and complete the transition we have initiated in IT,” said Wolfgang Nickl, Chief Financial Officer of Bayer AG. “We would like to thank Daniel for his outstanding commitment and the way he has shaped our IT for over a decade. We wish him every success for the future.”
“Now is a good time for me to hand over the reins and focus on other aspects of my life after more than 30 years of working at major corporations. The groundwork for the IT organization at Bayer has been laid, paving the way for Bijoy and the IT leadership team to take the digital transformation at Bayer to the next level,” emphasized Hartert. Sagar will start at Bayer on April 1, 2020, giving him time to prepare for the task ahead and to ensure a smooth handover. In his new function, he will be reporting to the Chief Financial Officer.
Sagar is joining Bayer from U.S. medical technology company Stryker, where he was also a member of the executive team as Chief Digital Technology Officer. In these roles, he developed and implemented the company’s digital strategy and was responsible for global IT. Sagar has worked for Stryker since 2014 and has over 20 years of experience in the healthcare and chemical sectors. He has previously worked for pharma and biotech companies Millennium Pharmaceuticals, Amgen, Eli Lilly & Company and Merck KGaA. It was during his time in Merck KGaA that he gained professional experience in Switzerland and Germany. Sagar studied science at the University of Mumbai as well as Northeastern University, Boston and holds US citizenship.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.com.
Find more information at www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
View Download Center